13F-HR filed by Altium Capital Management LLC
Altium Capital Management LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-15, with 68 holding rows worth $245,120,808.
- Accession
- 0001420506-24-001576
- Filer
- CIK 1746382
- Filed
- 2024-08-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 68 entries on the cover page, a total value of $245,120,808 stated on the cover page (in dollars after the unit check, H1), rows summing to $245,120,808 with VALUE read as dollars as filed, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 714,000 | $25,832,520 | dollars as filed | |
| ADMA BIOLOGICS INC | 000899104 | COM | 1,510,000 | $16,881,800 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 360,600 | $14,059,794 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 193,000 | $13,218,570 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 81,900 | $12,940,200 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 190,000 | $12,730,000 | dollars as filed | |
| ALIMERA SCIENCES INC | 016259202 | COM | 2,150,000 | $11,954,000 | dollars as filed | |
| SKYE BIOSCIENCE INC | 83086J200 | COM NEW | 1,350,093 | $10,814,245 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 23,000 | $9,890,920 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 212,909 | $8,686,687 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 610,000 | $8,576,600 | dollars as filed | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 500,000 | $7,745,000 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 429,340 | $7,560,677 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,700,000 | $7,310,000 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 50,000 | $6,819,000 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 122,000 | $6,467,220 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,575,000 | $6,347,250 | dollars as filed | |
| ZEVRA THERAPEUTICS INC COM NEW | 488445206 | Stock | 1,162,416 | $5,695,838 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 115,000 | $5,056,550 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 693,000 | $5,024,250 | dollars as filed | |
| XTANT MED HLDGS INC | 98420P308 | COM NEW | 7,415,413 | $4,671,711 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 50,000 | $4,025,000 | dollars as filed | |
| THE REALREAL INC | 88339P101 | COM | 1,250,238 | $3,988,259 | dollars as filed | |
| CYBIN INC | 23256X100 | COM | 13,953,488 | $3,781,395 | dollars as filed | |
| OUTLOOK THERAPEUTICS INC | 69012T305 | COM | 501,785 | $3,703,173 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 70,000 | $2,877,000 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 405,000 | $2,863,350 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 2,276,692 | $1,915,381 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 191,450 | $1,908,757 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 196,000 | $1,421,000 | dollars as filed | call |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 1,012,368 | $1,336,326 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 216,310 | $1,016,657 | dollars as filed | |
| NULL | 02008G102 | NULL | 969,840 | $967,512 | dollars as filed | |
| ANNOVIS BIO INC | 03615A108 | COM | 155,300 | $894,528 | dollars as filed | put |
| BIOVIE INC | 09074F207 | COM | 1,982,341 | $793,928 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 360,001 | $721,802 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 740,000 | $642,024 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 200,000 | $610,000 | dollars as filed | call |
| FAT BRANDS INC | 30258N121 | *W EXP 07/16/202 | 200,000 | $569,000 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 137,197 | $558,392 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 811,167 | $419,941 | dollars as filed | |
| EVOKE PHARMA INC | 30049G203 | COM NEW | 692,440 | $366,301 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 83,149 | $321,787 | dollars as filed | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 121,986 | $204,936 | dollars as filed | |
| INTELLIGENT BIO SOLUTIONS IN | 36151G600 | COM | 83,906 | $161,100 | dollars as filed | |
| PERFECT MOMENT LTD | 713715100 | COM SHS | 62,835 | $135,095 | dollars as filed | |
| NEXGEL INC | 65344E115 | *W EXP 12/27/202 | 225,000 | $98,325 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 20,000 | $80,600 | dollars as filed | call |
| CEMTREX INC | 15130G709 | COM NEW | 339,961 | $74,791 | dollars as filed | |
| WEARABLE DEVICES LTD | M97838110 | *W EXP 09/14/202 | 1,411,600 | $70,015 | dollars as filed | |
| QUOIN PHARMACEUTICALS ADR | 74907L300 | COM | 103,127 | $59,814 | dollars as filed | |
| ONFOLIO HOLDINGS INC | 68277K124 | *W EXP 01/02/202 | 200,000 | $49,760 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 731,561 | $44,406 | dollars as filed | |
| NEXALIN TECHNOLOGY INC | 65345B110 | *W EXP 99/99/999 | 105,000 | $35,700 | dollars as filed | |
| APPLIED DNA SCIENCES INC | 03815U409 | COM NEW | 86,152 | $35,184 | dollars as filed | |
| Vsee Health Inc W Exp 99/99/999 | 92919Y110 | SPAC Combination | 150,000 | $32,460 | dollars as filed | |
| MOBIX LABS INC | 60743G118 | *W EXP 12/21/202 | 150,000 | $26,820 | dollars as filed | |
| NLS PHARMACEUTICS LTD | H57830111 | *W EXP 02/02/202 | 200,000 | $6,900 | dollars as filed | |
| CEA INDUSTRIES INC | 86887P119 | *W EXP 02/11/202 | 250,000 | $3,750 | dollars as filed | |
| CYCURION INC | 95758L115 | *W EXP 02/13/203 | 100,000 | $3,660 | dollars as filed | |
| Cingulate Inc W Exp 12/10/202 | 17248W113 | Warrant | 270,000 | $2,916 | dollars as filed | |
| BITCOIN DEPOT INC | 09174P113 | *W EXP 06/30/202 | 50,000 | $2,365 | dollars as filed | |
| NEXERA TECHNOLOGIES LTD | M61472110 | *W EXP 08/26/202 | 68,681 | $2,198 | dollars as filed | |
| Cdt Equity Inc W Exp 09/22/202 | 20678X114 | SPAC Combination | 100,000 | $1,550 | dollars as filed | |
| COLISEUM ACQUISITION CORP | G2263T107 | *W EXP 08/22/202 | 28,333 | $1,417 | dollars as filed | |
| SURROZEN INC | 86889P117 | *W EXP 08/01/203 | 82,233 | $1,365 | dollars as filed | |
| BOA ACQUISITION CORP | g8059b119 | WT | 101,439 | $1,101 | dollars as filed | |
| TC BIOPHARM HOLDINGS PLC | 87807D111 | *W EXP 02/10/202 | 18,823 | $235 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-001576 | this filing | 2024-08-15 | acceptance time not in the bulk data set |